Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program
Crossref DOI link: https://doi.org/10.1186/s12955-016-0529-0
Published Online: 2016-09-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wiklund, Ingela
Anatchkova, Milena
Oko-Osi, Hafiz
von Maltzahn, Robyn
Chau, Dina
Malik, Fady I.
Patrick, Donald L.
Spertus, John
Teerlink, John R.
Funding for this research was provided by:
Amgen Inc.